(VRTU, ULBI, FURX) CRWENewswire Stocks to Watch
Ultralife Corp - ULBI - reported that it has received a contract to supply 2,319 of its A-320 amplifier systems to a major international defense contractor. On its third quarter fiscal 2012, Virtusa Corp - VRTU - posted revenue of $72.2 million, an increase of 3% sequentially and 30% year-over-year. Furiex Pharmaceuticals Inc - FURX - reported that the European Commission endorsed the positive opinion adopted by the Committee for Human Medicinal Products on October 18, 2011 for Priligy (dapoxetine) 30 and 60 mg doses.

*********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

ユーザー：karmastock
再生時間：00:01:13
投稿日時：12/02/01 9:44
カテゴリ：ビジネス全般 
タグ： ULBI  VRTU  FURX  Nasdaq:FURX  Nasdaq:VRTU  Nasdaq:ULBI 

[ 前ページへ戻る ]